-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BdZJX1igoRwI4DOiVlhhKyhgzR9twi5FtHm6YnmcqjnIOUKWp9Bx13NZqfJ1Y/+a h1VcclPJJWgkb9mwlhZMZQ== 0001144204-07-043385.txt : 20070814 0001144204-07-043385.hdr.sgml : 20070814 20070814153041 ACCESSION NUMBER: 0001144204-07-043385 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070630 FILED AS OF DATE: 20070814 DATE AS OF CHANGE: 20070814 EFFECTIVENESS DATE: 20070814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BAKER BROS ADVISORS LLC CENTRAL INDEX KEY: 0001263508 IRS NUMBER: 134093645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10519 FILM NUMBER: 071054649 BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125212418 13F-HR 1 v084642_13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2007 Check here if Amendment [ ]; Amendment Number: _____ This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Baker Bros. Advisors, LLC -------------------------------------------- Address: 667 Madison Avenue, 17th Floor -------------------------------------------- New York, NY 10065-8029 -------------------------------------------- Form 13F File Number: 28-10519 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Leo Kirby -------------------------------------------- Title: Chief Financial Officer -------------------------------------------- Phone: 212-339-5633 -------------------------------------------- Signature, Place, and Date of Signing: /s/ Leo Kirby New York, N.Y. August 14, 2007 - -------------------------- --------------------------- ---------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: None FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------- Form 13F Information Table Entry Total: 90 ----------- Form 13F Information Table Entry Value: 1,039,277 ----------- (thousands) List of Other Included Managers: None
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - ----------------- ----- ----- -------- ------- --- ---- ---------- -------- ---- ------ ---- Acadia Pharmaceuticals Inc. COM 004225108 28,688 2,098,595 SH SOLE 2,098,595 Acorda Therapeutics COM 00484M106 19,532 1,144,908 SH SOLE 1,144,908 Adolor Corp. COM 00724X102 946 254,921 SH SOLE 254,921 Advanced Magnetics COM 00753P103 2,908 50,000 SH SOLE 50,000 Alkermes COM 01642T108 1,285 88,006 SH SOLE 88,006 Allos Therapeutics Inc. COM 019777101 38,637 8,741,480 SH SOLE 8,741,480 Altus Pharmaceuticals Inc. COM 02216N105 467 40,477 SH SOLE 40,477 Amicus Therapeutics COM 03152W109 6,319 549,491 SH SOLE 549,491 Amylin Pharmaceuticals Inc. COM 032346108 46,839 1,137,978 SH SOLE 1,137,978 Anesiva Inc. COM 21872P501 11,330 1,842,240 SH SOLE 1,842,240 AP Pharma COM 00202J203 2,879 1,515,152 SH SOLE 1,515,152 Aradigm Corp. COM 038505301 137 100,000 SH SOLE 100,000 Arena Pharmaceuticals Inc. COM 040047102 2,355 214,271 SH SOLE 214,271 Array Biopharma Inc. COM 04269X105 3,057 261,928 SH SOLE 261,928 Atherogenics Inc. COM 047439104 54 25,357 SH SOLE 25,357 Autoimmune Inc. COM 052776101 38 26,100 SH SOLE 26,100 Auxilium COM 05334D107 19,053 1,195,284 SH SOLE 1,195,284 Biocryst Pharmaceuticals Inc. COM 09058V103 13,541 1,751,744 SH SOLE 1,751,744 BioEnvision COM 09059N100 297 51,394 SH SOLE 51,394 Biomarin Pharmaceutical Inc. COM 09061G101 710 39,553 SH SOLE 39,553 Cerus Corp. COM 157085101 7,574 1,120,468 SH SOLE 1,120,468 Chelsea Therapeutics COM 163428105 4,578 684,309 SH SOLE 684,309 Coley Pharmaceutical Group Inc. COM 19388P106 2,069 573,098 SH SOLE 573,098 Critical Therapeutics Inc. COM 22674T105 2,501 1,146,913 SH SOLE 1,146,913 Curis Inc. COM 231269101 31 26,800 SH SOLE 26,800 Cyclacel Pharmaceuticals COM 23254L108 1,777 273,386 SH SOLE 273,386 Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% PFD CONV EX 23254L207 610 95,500 SH SOLE 95,500 Cytokinetics Inc. COM 23282W100 9,664 1,710,416 SH SOLE 1,710,416 Emergent Biosolutions COM 29089Q105 3,572 346,800 SH SOLE 346,800 Epix Pharmaceuticals COM 26881Q309 433 77,106 SH SOLE 77,106 Exelisis COM 30161Q104 928 76,657 SH SOLE 76,657 Genelabs Technologies Inc. COM 368706206 1,790 761,894 SH SOLE 761,894 Genomic Health Inc. COM 37244C101 90,110 4,793,090 SH SOLE 4,793,090 Halozyme Therapeutics Inc. COM 40637H109 7,614 824,933 SH SOLE 824,933 Icagen Inc. COM 45104P104 151 75,468 SH SOLE 75,468 Idera Pharmaceuticals Inc. COM 45168K108 16,273 2,272,725 SH SOLE 2,272,725 Immunogen Inc. COM 45253H101 1,582 285,100 SH SOLE 285,100 Incyte Corp. COM 45337C102 19,260 3,209,917 SH SOLE 3,209,917 Indevus Pharmaceuticals COM 454072109 606 90,000 SH SOLE 90,000 Infinity Pharmaceuticals Inc. COM 45665G303 932 85,651 SH SOLE 85,651 Intermune Inc. COM 45884X103 37,102 1,430,285 SH SOLE 1,430,285 Isis Pharmaceuticals Inc. COM 464330109 183 18,859 SH SOLE 18,859 Kosan COM 50064W107 12,550 2,404,284 SH SOLE 2,404,284 Ligand Pharmaceuticals Inc. CL B 53220K207 263 38,224 SH SOLE 38,224 Medarex Inc. COM 583916101 5,776 404,191 SH SOLE 404,191 Memory Pharma COM 58606R403 363 153,006 SH SOLE 153,006 Metabasis Therapeutics Inc. COM 59101M105 16,901 2,414,466 SH SOLE 2,414,466 Micromet COM 59509C105 5,065 2,221,614 SH SOLE 2,221,614 Myriad Genetics Inc. COM 62855J104 30,489 819,821 SH SOLE 819,821 Neopharm Inc. COM 640919106 159 138,041 SH SOLE 138,041 Neose Technologies Inc. COM 640522108 5,499 2,235,590 SH SOLE 2,235,590 Neurogen Corp. COM 64124E106 34,177 5,147,078 SH SOLE 5,147,078 Novo-Nordisk COM 670100205 22,803 210,028 SH SOLE 210,028 Onyx Inc. COM 683399109 3,380 125,650 SH SOLE 125,650 Optimer Pharmaceuticals COM 68401H104 11,238 1,250,000 SH SOLE 1,250,000 OSI Pharmaceuticals COM 671040103 6,294 173,826 SH SOLE 173,826 Palatin Technologies COM 696077304 498 251,350 SH SOLE 251,350 Pharmacyclics Inc. COM 716933106 880 323,598 SH SOLE 323,598 Pharmasset Inc. COM 71715N106 236 26,975 SH SOLE 26,975 Pharmion Corp. COM 71715B409 35,791 1,236,305 SH SOLE 1,236,305 Poniard Pharmaceuticals Inc. COM 732449301 306 45,002 SH SOLE 45,002 Pozen Inc. COM 73941U102 554 30,652 SH SOLE 30,652 Savient Pharmaceuticals, Inc. COM 80517Q100 1,163 93,667 SH SOLE 93,667 Seattle Genetics Inc. COM 812578102 46,231 4,712,589 SH SOLE 4,712,589 Siga Technologies Inc. COM 826917106 3,650 1,109,461 SH SOLE 1,109,461 Sirtris Pharmaceuticals Inc. COM 82968A105 1,207 122,280 SH SOLE 122,280 Spectrum Pharmaceuticals Inc. COM 84763A108 5,757 802,962 SH SOLE 802,962 Sunesis Pharmaceuticals Inc. COM 867328502 4,616 1,296,739 SH SOLE 1,296,739 Supergen COM 868059106 248 44,600 SH SOLE 44,600 Symyx Technologies, Inc. COM 87155S108 3,483 302,621 SH SOLE 302,621 Tapestry Pharmaceuticals Inc. COM 876031204 3,740 2,000,000 SH SOLE 2,000,000 Targacept COM 87611R306 1,318 144,050 SH SOLE 144,050 Theravance Inc. COM 88338T104 13,148 410,869 SH SOLE 410,869 Threshold Pharma COM 885807107 2,833 2,303,100 SH SOLE 2,303,100 Torreypines Therapeutics COM 89235K105 1,421 204,465 SH SOLE 204,465 Trimeris Inc. COM 896263100 23,675 3,461,175 SH SOLE 3,461,175 Vertex Pharmaceuticals Inc. COM 92532F100 46,227 1,618,599 SH SOLE 1,618,599 Viacell COM 92554J105 55 10,024 SH SOLE 10,024 Via Pharmaceuticals COM 92554T103 136 27,718 SH SOLE 27,718 Viropharma Inc. COM 928241108 83,413 6,044,413 SH SOLE 6,044,413 Xenoport Inc. COM 98411C100 43,883 987,918 SH SOLE 987,918 Zymogenetics Inc. COM 98985T109 723 49,502 SH SOLE 49,502 Alexion Pharmaceuticals Notes 1.375% 2/01/2012 CONV BONDS 015351AF6 12,803 8,300,000 PRN SOLE 8,300,000 Amylin Pharmaceuticals Notes 2.5% 4/15/11 CONV BONDS 032346AD0 12,224 8,980,000 PRN SOLE 8,980,000 Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 CONV BONDS 09061GAD3 12,870 12,000,000 PRN SOLE 12,000,000 Biomarin Pharmaceuticals Notes 2.5% 3/29/2013 CONV BONDS 09061GAC5 23,815 18,569,000 PRN SOLE 18,569,000 Incyte Genomics Notes 3.5% 2/15/2011 CONV BONDS 45337CAE2 16,624 18,972,000 PRN SOLE 18,972,000 Intermune Inc Notes .25% 3/01/2011 CONV BONDS 45884XAC7 11,592 8,500,000 PRN SOLE 8,500,000 Medarex Inc Notes 2.25% 5/15/2011 CONV BONDS 583916AG6 17,025 13,472,000 PRN SOLE 13,472,000 Viropharma Inc. Notes 2.0% 3/15/2017 CONV BONDS 928241AH1 43,763 45,000,000 PRN SOLE 45,000,000
-----END PRIVACY-ENHANCED MESSAGE-----